Tiffany Roe, APRN
Family · Shreveport, LANPI 1548661440
Payments from drug & device makers
Across 1,118 payments — averaging $86.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$41K
- AbbVie$22K
- Amgen$15K
- Novartis$4K
- Johnson & Johnson$3K
- Mallinckrodt Hospital Products Inc.$2K
- plus $10K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 127 | $40,768 |
| AbbVie | 207 | $21,885 |
| Amgen(2 entities) | 292 | $14,886 |
| Novartis | 82 | $4,239 |
| Johnson & Johnson | 73 | $3,063 |
| Mallinckrodt Hospital Products Inc. | 36 | $2,072 |
| UCB, Inc. | 88 | $1,824 |
| Sobi, Inc | 4 | $1,730 |
| Eli Lilly | 2 | $1,234 |
| E.r. Squibb & Sons, L.L.C. | 19 | $1,212 |
| AstraZeneca(2 entities) | 28 | $699 |
| Pfizer | 44 | $591 |
| Radius Health, Inc. | 24 | $524 |
| GSK | 19 | $515 |
| Sanofi | 8 | $443 |
| Genentech USA, Inc. | 20 | $339 |
| Boehringer Ingelheim | 11 | $284 |
| Aurinia Pharma U.S., Inc. | 10 | $196 |
| Pacira Therapeutics, Inc. | 4 | $188 |
| ANI Pharmaceuticals, Inc. | 4 | $68 |
| Organon | 4 | $57 |
| Actelion Pharmaceuticals US, Inc. | 3 | $46 |
| Kyowa Kirin, Inc. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Scilex Pharmaceuticals Inc. | 1 | $25 |
| Invivyd Inc | 1 | $22 |
| Almatica Pharma LLC | 1 | $21 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
| Cumberland Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$97,029 in reported general payments places this provider in the 95th percentile of 3,610 family providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Shreveport
- Bridget LeeShreveport$44K
- Alicia SchollmeyerShreveport$14K
- Kirby CoxShreveport$14K
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.